Travere Therapeutics Inc
TVTX
Health Care
2
exclusion reasons
1 theme
Travere Therapeutics Inc is screened out under 2 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Travere Therapeutics Inc. conducts pre-clinical studies of its drugs on animals to assess safety and efficacy. This is a standard practice in pharmaceutical development, but it constitutes commercial exploitation of animals under the firm's policy. The company’s pipeline and approved products, including FILSPARI® (sparsentan), rely on animal testing data for regulatory submissions and approvals.
Travere Therapeutics is a biopharmaceutical company whose drug development pipeline requires animal testing as a core component of its preclinical research. The company’s public filings, including its 2025 Form 10-K, explicitly state that its drug development process includes the “completion of extensive preclinical laboratory tests, animal studies and clinical trials.” This reliance on animal models is a standard, required step for regulatory approval of its investigational therapies, such as sparsentan for rare kidney diseases. The company is listed by Cruelty Free Investing as conducting pre-clinical animal studies to assess drug safety and efficacy. As a pharmaceutical company developing novel chemical entities, Travere Therapeutics funds and commissions animal testing as an integral part of its product development and regulatory compliance process.
Research Sources
8 organizations
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.